Nutritional Factors and Hair Loss During GLP-1 Therapy Patients on tirzepatide often experience reduced appetite and nausea, which can make it harder to consume enough protein, iron, zinc, and B vitaminsall essential for healthy hair growth
PT-141 Synonyms / Designations: PT-141, Bremelanotide, Melanotan II analogue CAS Number: 189691-06-3 Molecular Formula: C50H68N14O10 Molecular Weight: ~1025.18 g/mol Peptide Length: 7 amino acids (cyclic peptide) Peptide Type: Synthetic melanocortin receptor agonist Purity: 99 % (HPLC, typical) Appearance: White to off-white lyophilised powder Pack Size: 10 mg (typical) Storage : Desiccated, protected from light, stored at 20 C or below Solubility: Soluble in water and buffered aqueous solutions Description & Mechanism PT-141 is a synthetic cyclic heptapeptide derived from melanocortin peptides and developed for experimental investigation of melanocortin receptormediated signalling pathways
It can have a synergistic effect on bone health, immune function, and energy levels
In this context, GLP-1s and other weightmanagement medications may be most effective when they are: Anchored to clear clinical criteria and outcome-based continuation policies, so that ongoing coverage aligns with demonstrated health improvement and adherence Integrated into broader chronic disease and wellness strategies that emphasize long-term behavioral change, rather than positioned as standalone, short-term solutions By incorporating this emerging evidence into GLP1 benefit design, employers can better balance access, outcomes, and sustainability, supporting employee health while setting realistic expectations about the need for ongoing management to maintain results over time
Jul 2025;35(4):531-538
You might lose weight, but you'll feel like garbage